Inventor

TARTAR ANDRE

FR11 patents

⚠️ This page may combine multiple inventors who share the name “TARTAR ANDRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PASTEUR INSTITUT

6 patents

US5993823ANov 30, 1999

Cytotoxic T lymphocyte-inducing lipopeptides and methods of use

PASTEUR INSTITUT22 citations89

US4499080AFeb 12, 1985

Synthetic ST toxin, process for its preparation and its use as a vaccinating agent

PASTEUR INSTITUT30 citations83

US6015564AJan 18, 2000

Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines

PASTEUR INSTITUT13 citations70

US5824788AOct 20, 1998

Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications

PASTEUR INSTITUT7 citations68

US5541078AJul 30, 1996

Antigenic peptide sequence of echinococcus granulosus and diagnostic applications

PASTEUR INSTITUT12 citations67

US6818219B1Nov 16, 2004

Reagent for detecting and monitoring viral infections

PASTEUR INSTITUT10 citations66

INST NAT SAINTE ET DE LA RECH

1 patent

US5871746AFeb 16, 1999

Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines

INST NAT SAINTE ET DE LA RECH59 citations90

INST NAT SANTE RECH MED

1 patent

US7476386B1Jan 13, 2009

Mixed lipopeptide micelles for inducing an immune response

INST NAT SANTE RECH MED32 citations86

UNIV TENNESSEE RES CORP

1 patent

US4695562ASep 22, 1987

Synthetic peptide compounds

UNIV TENNESSEE RES CORP21 citations81

(unassigned)

1 patent

US6392014B1May 21, 2002

Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications

10 citations67

FERRING BV

1 patent

US7144886B2Dec 5, 2006

Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents

FERRING BV4 citations62